[1] |
HOU Xiaoyu, LENG Yufang, CAO Xuefen, LV Xingjiao, HAN Xiaoxia, Janvier NIBARUTA, LIU Yongqiang.
Network analysis and experimental verification of Schisandrin B reduces intestinal ischemia reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 147-154.
|
[2] |
WANG Wenjuan, QI Mingrui, TIAN Limin.
Research progress on Nrf2 in diabetic cardiomyopathy and intervention of traditional Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1163-1170.
|
[3] |
XU Ke, GAO Junwei, LIU Peng, SHEN Zhengri, JIA Hui, WU Chenguang, TIAN Feng, WANG Lifan, LI Ping.
Tangshen formula improves cholesterol uptake and efflux of macrophages induced by high lipid via activating PGC-1α/LXR/ABCA1 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 978-985.
|
[4] |
LIU Xiaoping, LAI Xiangmao, OUYANG Zizhang, JIANG Sheng, ZHANG Ying.
Nobiletin inhibits neonatal rat cardiomyocytes hypertrophy induced by high glucose
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 753-759.
|
[5] |
ZHANG Weiping, JIANG Jianjun, CHEN Xiaofeng, XU Shasha.
Gardenoside alleviates diabetic cardiomyopathy via inhibiting VPO1/ERK1/2 signaling pathway to improve myocardial apoptosis in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 129-136.
|
[6] |
LI Zhuqing, JU Yinghui, CHEN Qingqing, MA Keke, LI Weiping.
Protective effects of Astragaloside Ⅳ on early kidney damage in diabetes mellitus rats and its mechanisms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 255-262.
|
[7] |
YE Haizhu, CHEN Yajuan, ZHAO Wenying, LIU Xiaoping.
Different expression of FoxO3/Keap1/Nrf2 pathway in tumor cells and drug resistant tumor cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 859-865.
|
[8] |
MAO Jiading, HU Di, WU Pei.
Effects of gastrin on ERK signaling pathway in the proliferation of colorectal cancer cell line CACO2
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 401-405.
|
[9] |
GE Meng-Xue, QU Qiang, ZHOU Hong-Hao.
Advances in study on effective components of Chinese medicine regulating Nrf2-Keap1-ARE signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(6): 707-712.
|
[10] |
ZENG Wei-xian, DAI Yuan-rong.
Prevention by caveolin-1 of the proliferation of the asthmatic airway smooth muscle cells is most likely mediated by ERK1/2 signal pathway and regulation of roxithromycin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 632-638.
|
[11] |
CAO Shan, ZHOU Gan, PENG Xiang-dong, YANG Guo-ping, ZHOU Hong-hao.
Role of Nrf2 in neuroprotection and its mechanisms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(6): 696-704.
|
[12] |
HU Xin, SONG Shu-hui, XIONG Yu-qing, CAI Li-ping.
Effects of Naringin on expression of p38MAPK and ERK1/2 signaling proteins of Human ovarian cancer cell line SKOV3
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(5): 519-523.
|
[13] |
LIU Ai-hua1, SHI Meng-qiong1, YAN Wen-yan1, YANG Wei-hong1, GONG Xue-qian1, XIONG Yan-qiang1, ZHOU Ji-gang2, LUO Tao2, ZHANG Ji-hong2.
Cardioprotective effect and its mechanism of total saponin from Panacis majoris rhizoma on myocardium ischemia/reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(11): 1224-1232.
|
[14] |
LI Wei, CHEN Li-ping, LI Li, XU Guang-lin, HE Shu-ying.
Effect of twelve-degree of polymerization heparin oigosaccharide on proliferation in vascular smooth muscle cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(8): 862-866.
|
[15] |
LAI Li-na, REN Ze-en, YANG Liu-xu, ZHANG Xiao-yi, WANG Li-min, FAN Yi-min.
ERK1/2 signal transduction pathway in anti-proliferation effect of PDGF-BB on HSC cells treated with Artesunate
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(2): 126-129.
|